NASDAQ:NYMX

Delisted

Nymox Pharmaceutical Corporation Stock News

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.200

+0 (+0%)

At Close: Nov 10, 2023

Stocks Which Set New 52-Week Low Yesterday, October 3rd

12:00am, Thursday, 04'th Oct 2018

Nymox Reports 'no identifiable risks or serious side effects or adverse events identified associated or linked with' Fexapotide Treatments For Prostate Cancer, Benign Prostatic Hyperplasia

12:00am, Wednesday, 03'rd Oct 2018

Stocks Which Set New 52-Week Low Yesterday, October 1st

01:24pm, Tuesday, 02'nd Oct 2018

Stocks Which Set New 52-Week Low Yesterday, August 15th

03:15pm, Thursday, 16'th Aug 2018

The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait

12:00am, Thursday, 16'th Aug 2018

55 Stocks Moving In Wednesday's Mid-Day Session

12:00am, Wednesday, 15'th Aug 2018

Nymox Pharmaceutical Q2 EPS $(0.04) vs $(0.05) In Same Qtr. Last Year, Sales $88.411K vs $9.432K YoY

12:00am, Monday, 13'th Aug 2018

44 Biggest Movers From Yesterday

12:00am, Tuesday, 03'rd Jul 2018

'$NYMX PR headline: "NYMOX Announces Expanded Marketing Plans" But then you read down to 4th paragraph where it says the EMA submission has been withdrawn. Oh…' - STAT News' Adam F Tweets

12:00am, Monday, 02'nd Jul 2018

44 Biggest Movers From Yesterday

12:00am, Tuesday, 26'th Jun 2018

36 Stocks Moving In Monday's Mid-Day Session

12:00am, Monday, 25'th Jun 2018

Nymox ramps up manufacturing of fexapotide triflutate; shares up 4%

12:00am, Thursday, 07'th Jun 2018

Nymox Pharma Reports Initiation Of Process To Relocate Co. HQ From Nassau, Bahamas To Zug, Switzerland

12:00am, Monday, 07'th May 2018

Nymox Announces $16.25M Equity Financing With Qualified Long-Term Investors; Lead Investor Will Receive 2.5M Warrants At $8/Share For Their $12M Investment

Nymox Pharmaceutical Corporation Stock News

Stocks Which Set New 52-Week Low Yesterday, October 3rd

Nymox Reports 'no identifiable risks or serious side effects or adverse events identified associated or linked with' Fexapotide Treatments For Prostate Cancer, Benign Prostatic Hyperplasia

Stocks Which Set New 52-Week Low Yesterday, October 1st

Stocks Which Set New 52-Week Low Yesterday, August 15th

The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait

55 Stocks Moving In Wednesday's Mid-Day Session

Nymox Pharmaceutical Q2 EPS $(0.04) vs $(0.05) In Same Qtr. Last Year, Sales $88.411K vs $9.432K YoY

44 Biggest Movers From Yesterday

'$NYMX PR headline: "NYMOX Announces Expanded Marketing Plans" But then you read down to 4th paragraph where it says the EMA submission has been withdrawn. Oh…' - STAT News' Adam F Tweets

44 Biggest Movers From Yesterday

36 Stocks Moving In Monday's Mid-Day Session

Nymox ramps up manufacturing of fexapotide triflutate; shares up 4%

Nymox Pharma Reports Initiation Of Process To Relocate Co. HQ From Nassau, Bahamas To Zug, Switzerland

Nymox Announces $16.25M Equity Financing With Qualified Long-Term Investors; Lead Investor Will Receive 2.5M Warrants At $8/Share For Their $12M Investment

38 Biggest Movers From Yesterday

Top Fintech Company

Sign In

Nymox Pharmaceutical Corporation Stock News

Stocks Which Set New 52-Week Low Yesterday, October 3rd

Nymox Reports 'no identifiable risks or serious side effects or adverse events identified associated or linked with' Fexapotide Treatments For Prostate Cancer, Benign Prostatic Hyperplasia

Stocks Which Set New 52-Week Low Yesterday, October 1st

Stocks Which Set New 52-Week Low Yesterday, August 15th

The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait

55 Stocks Moving In Wednesday's Mid-Day Session

Nymox Pharmaceutical Q2 EPS $(0.04) vs $(0.05) In Same Qtr. Last Year, Sales $88.411K vs $9.432K YoY

44 Biggest Movers From Yesterday

'$NYMX PR headline: "NYMOX Announces Expanded Marketing Plans" But then you read down to 4th paragraph where it says the EMA submission has been withdrawn. Oh…' - STAT News' Adam F Tweets

44 Biggest Movers From Yesterday

36 Stocks Moving In Monday's Mid-Day Session

Nymox ramps up manufacturing of fexapotide triflutate; shares up 4%

Nymox Pharma Reports Initiation Of Process To Relocate Co. HQ From Nassau, Bahamas To Zug, Switzerland

Nymox Announces $16.25M Equity Financing With Qualified Long-Term Investors; Lead Investor Will Receive 2.5M Warrants At $8/Share For Their $12M Investment

38 Biggest Movers From Yesterday

Top Fintech Company